findmyKOL

Gene Kwan, MD

Basic profile

Boston University

ORCID↗NPI↗
✓ Full record
RegionBoston, MA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH funding2019–2026Why? →

Gene Kwan is a Cardiology physician affiliated with Boston University. OpenAlex indexes 100 publications with 64,832 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
100publications

Distinct works indexed by OpenAlex, matched via ORCID.

64,832citations

Total citations across indexed works.

30h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
3NIH grants · 2019–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

732 Harrison Ave
Preston Bldg Fl 3
Boston, MA 021182526

Telephone

617-638-7490

Provider last certified this registry record 13 Apr 2026.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    78.3%
    Statin21.5%
    Atorvastatin Calcium65%Rosuvastatin Calcium35%
    Part D≥20 patients
    Beta blocker19.1%
    Metoprolol Succinate80%Carvedilol20%
    Part D<11 patients

    + 8 more classes in this area

  • Blood & clotting

    18.1%
    Factor Xa inhibitor18.1%
    Eliquis100%
    Part D≥17 patients
  • Metabolism & gastrointestinal

    3.6%
    SGLT2 inhibitor3.6%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

3 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”